VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 52 filers reported holding VERRICA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,027 | -23.1% | 23,433 | +14.2% | 0.00% | – |
| Q2 2023 | $118,388 | +13.8% | 20,518 | +60.7% | 0.00% | – |
| Q1 2022 | $104,000 | -14.8% | 12,769 | -4.3% | 0.00% | – |
| Q4 2021 | $122,000 | -24.7% | 13,348 | +2.9% | 0.00% | – |
| Q3 2021 | $162,000 | +11.7% | 12,976 | +1.0% | 0.00% | – |
| Q2 2021 | $145,000 | -28.9% | 12,844 | -4.4% | 0.00% | – |
| Q1 2021 | $204,000 | +25.9% | 13,434 | -4.7% | 0.00% | – |
| Q4 2020 | $162,000 | +58.8% | 14,094 | +6.9% | 0.00% | – |
| Q3 2020 | $102,000 | -39.6% | 13,184 | -14.0% | 0.00% | – |
| Q2 2020 | $169,000 | -10.6% | 15,324 | -11.6% | 0.00% | – |
| Q1 2020 | $189,000 | -31.0% | 17,327 | +0.6% | 0.00% | – |
| Q4 2019 | $274,000 | +9.6% | 17,227 | +1.8% | 0.00% | – |
| Q3 2019 | $250,000 | +34.4% | 16,918 | +5.6% | 0.00% | – |
| Q2 2019 | $186,000 | +67.6% | 16,020 | +56.3% | 0.00% | – |
| Q1 2019 | $111,000 | – | 10,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 108,794 | $1,252,000 | 0.47% |
| Perceptive Advisors | 3,410,412 | $39,254,000 | 0.42% |
| KNOTT DAVID M | 76,585 | $881,000 | 0.40% |
| Fosun International Ltd | 324,061 | $3,730,000 | 0.24% |
| Orbimed Advisors | 1,479,733 | $17,032,000 | 0.15% |
| SteelPeak Wealth, LLC | 132,961 | $1,530,000 | 0.14% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 665,511 | $7,660,000 | 0.13% |
| Capital Investment Advisory Services, LLC | 15,125 | $174,000 | 0.03% |
| BECK MACK & OLIVER LLC | 10,000 | $115,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 335,318 | $3,860,000 | 0.00% |